Literature DB >> 10554111

Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive.

P Lucas1, K Anderson, U J Potter, J N Staniforth.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10554111     DOI： 10.1023/a:1011981326827

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  5 in total

1.  Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers.

Authors:  P Lucas; K Anderson; J N Staniforth
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

2.  Large porous particles for pulmonary drug delivery.

Authors:  D A Edwards; J Hanes; G Caponetti; J Hrkach; A Ben-Jebria; M L Eskew; J Mintzes; D Deaver; N Lotan; R Langer
Journal:  Science       Date:  1997-06-20       Impact factor: 47.728

3.  The twin impinger: a simple device for assessing the delivery of drugs from metered dose pressurized aerosol inhalers.

Authors:  G W Hallworth; D G Westmoreland
Journal:  J Pharm Pharmacol       Date:  1987-12       Impact factor: 3.765

Review 4.  British Pharmaceutical Conference Science Award lecture 1986. Order out of chaos.

Authors:  J N Staniforth
Journal:  J Pharm Pharmacol       Date:  1987-05       Impact factor: 3.765

5.  A semi-empirical model of aerosol deposition in the human respiratory tract for mouth inhalation.

Authors:  I Gonda
Journal:  J Pharm Pharmacol       Date:  1981-11       Impact factor: 3.765
  5 in total
  10 in total

1.  Use of solid corrugated particles to enhance powder aerosol performance.

Authors:  N Y Chew; H K Chan
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

Review 2.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

3.  Chargeability measurements of selected pharmaceutical dry powders to assess their electrostatic charge control capabilities.

Authors:  Juan-Carlos Ramirez-Dorronsoro; Robert B Jacko; Dane O Kildsig
Journal:  AAPS PharmSciTech       Date:  2006       Impact factor: 3.246

4.  Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs.

Authors:  Lucila Garcia-Contreras; Danielle J Padilla-Carlin; Jean Sung; Jarod VerBerkmoes; Pavan Muttil; Katharina Elbert; Charles Peloquin; David Edwards; Anthony Hickey
Journal:  J Pharm Sci       Date:  2016-11-11       Impact factor: 3.534

5.  Intact nanoparticulate indomethacin in fast-dissolving carrier particles by combined wet milling and aerosol flow reactor methods.

Authors:  Timo Laaksonen; Peng Liu; Antti Rahikkala; Leena Peltonen; Esko I Kauppinen; Jouni Hirvonen; Kristiina Järvinen; Janne Raula
Journal:  Pharm Res       Date:  2011-05-04       Impact factor: 4.200

6.  A novel gas phase method for the combined synthesis and coating of pharmaceutical particles.

Authors:  Janne Raula; Anna Lähde; Esko I Kauppinen
Journal:  Pharm Res       Date:  2007-10-20       Impact factor: 4.200

7.  Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin.

Authors:  Jennifer Fiegel; Lucila Garcia-Contreras; Matthew Thomas; Jarod VerBerkmoes; Katharina Elbert; Anthony Hickey; David Edwards
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

8.  Lactose composite carriers for respiratory delivery.

Authors:  Paul M Young; Philip Kwok; Handoko Adi; Hak-Kim Chan; Daniela Traini
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

9.  Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations.

Authors:  Rinku A Tuli; Graeme A George; Tim R Dargaville; Nazrul Islam
Journal:  Pharm Res       Date:  2012-05-15       Impact factor: 4.200

10.  Development of Chitosan-based Dry Powder Inhalation System of Cisplatin for Lung Cancer.

Authors:  D J Singh; A A Lohade; J J Parmar; Darshana D Hegde; P Soni; A Samad; Mala D Menon
Journal:  Indian J Pharm Sci       Date:  2012-11       Impact factor: 0.975
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.